칼시메디커 (CALC) 주가

칼시메디커(CALC)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.92 (-2.54%), 시가총액 $9.80M, 52주 범위 $0.51 ~ $6.74.

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease.

핵심 지표

• 현재가: $1.92 (-2.54%)
• 시가총액: $9.80M
• 52주 최저~최고: $0.51 ~ $6.74
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NAS

칼시메디커의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

칼시메디커 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (4.8 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 7.13
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문